CHICAGO & SANDUSKY, Ohio–(BUSINESS WIRE)– #eyecare–Midwest Vision Partners announces its 8th partnership to date with Parschauer Eye Center, expanding its network to 95+ physicians and 44 locations.
Author: Business Wire
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will participa…
The Donate Life Community, Along With NJ Sharing Network and 14 Other Sponsors From Around the Nation, Invite Audiences to Watch the 2021 Rose Parade TV Special on New Year’s Day
LOS ANGELES–(BUSINESS WIRE)– #2021RoseParade–The Donate Life Community, NJ Sharing Network and 14 other sponsors invite audiences to watch the 2021 Rose Parade TV special on New Year’s Day.
Global Ocular Drug Delivery Market Overview, Delivery Technologies and Partnering Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Drug Delivery: Market Overview, Delivery Technologies and Partnering Opportunities, 2nd edition” report has been added to ResearchAndMarkets.com’s offering. Millions of people worldwide are affected by various eye d…
Global Contact Lens Market Insights & Forecast 2020-2024 with COVID-19 Impact Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market is forecasted to reach US$9.92 b…
VisionQuest Biomedical Inc. Gains FDA 510(k) Clearance for the Image Quality Analyzer Software
ALBUQUERQUE, N.M.–(BUSINESS WIRE)– #510k–VisionQuest Biomedical Inc. (VisionQuest) announced today that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the Image Quality Analyzer (IQA) so…
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
NEW YORK–(BUSINESS WIRE)– #FDA–Eyenovia has submitted an NDA to the FDA for MydCombi, a unique fixed combination mydriatic (pupil dilation) agent delivered by the Optejet dispenser.
Ocular TherapeutixTM Announces Exercise of Underwriters’ Option to Purchase Additional Shares
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market Research 2020-2024 | Post-Pandemic Industry Planning Structure by Technavio
LONDON–(BUSINESS WIRE)– #GlobalLaserAssistedInSituKeratomileusisLASIKSurgeryMarket–The Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market will grow by $ 375.04 mn during 2020-2024
Eyewear Market to Accelerate at a CAGR of Almost 8% | Research Report by Technavio
LONDON–(BUSINESS WIRE)– #GlobalEyewearMarket–The Eyewear Market will grow by USD 57.69 bn during 2020-2024
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
United Kingdom Spectacles and Googles Market Outlook to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United Kingdom: Spectacles and Googles 2014-2024” report has been added to ResearchAndMarkets.com’s offering. This report forecasts the market evolution at an average annual rate of -6.5% to the level of 205,010 thousand e…
Ocular Therapeutix™ Announces Submission to the FDA of a Supplemental New Drug Application for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
EyeSouth Partners Expands Presence in Houston with Eye Center of Texas Affiliation
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Eye Center of Texas (“ECT”). The affiliation represents EyeSouth’s third in the state of Texas and twentieth affi…
Medical Technology Company Heru, Inc. Completes FDA Registration Following a $2.7M Seed Round
MIAMI–(BUSINESS WIRE)–Heru, a Bascom Palmer Eye Institute medical technology company developing a next-generation AI platform for vision diagnostics and augmentation, today announces its class I listing with the U.S. Food and Drug Administration (FDA…
My Eyelab Opens New Stores in Houston Area
HOUSTON–(BUSINESS WIRE)–My Eyelab, a leading retail eye health provider offering accessible and affordable eye care and eyewear, recently opened its newest locations in Houston, Humble and Cypress, TX on December 14 and 21. The locations are as follo…
Azura Ophthalmics Announces Primary Endpoints Met in Topline Results from Phase 2 Trial of the Company’s Investigational Treatment for Contact Lens Discomfort
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye diseases, today announced topline results from a phase 2 cl…
Avellino Wins Prestigious Innovation Honors
MENLO PARK, Calif.–(BUSINESS WIRE)– #avellino–Avellino and Ulster University jointly honored with the highly-prestigious 2020 US-Ireland Research Innovation Award for rare genetic eye diseases.
Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase III Studies for Diabetic Macular Edema, a Leading Cause of Blindness
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global Phase III studies, YOSEMITE and RHINE, evaluating its invest…
Ophthalmology Devices Market 2020-2024- Featuring Alcon Inc., Allergan Plc, Bausch Health Companies Inc., Among Others to Contribute to the Market Growth
LONDON–(BUSINESS WIRE)– #GlobalOphthalmologyDevicesMarket–The Ophthalmology Devices Market will grow by USD 13.03 bn during 2020-2024